5-fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications

Int J Biol Macromol. 2011 Jan 1;48(1):98-105. doi: 10.1016/j.ijbiomac.2010.10.003. Epub 2010 Oct 14.

Abstract

In this study, 5-flurouracil loaded fibrinogen nanoparticles (5-FU-FNPs) were prepared by two step coacervation method using calcium chloride as cross-linker. The prepared nanoparticles were characterized using DLS, SEM, AFM, FT-IR, TG/DTA and XRD studies. Particle size of 5-FU-FNPs was found to be 150-200 nm. The loading efficiency (LE) and in vitro drug release was studied using UV spectrophotometer. The LE of FNPs was found to be ∼90%. The cytotoxicity studies showed 5-FU-FNPs were toxic to MCF7, PC3 and KB cells while they are comparatively non toxic to L929 cells. Cellular uptake of Rhodamine 123 conjugated 5-FU-FNPs was also studied. Cell uptake studies demonstrated that the nanoparticles are inside the cells. These results indicated that FNPs could be useful for cancer drug delivery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cattle
  • Cell Death / drug effects
  • Cell Line, Tumor
  • Drug Delivery Systems / methods*
  • Fibrinogen / pharmacology*
  • Fluorouracil / chemistry
  • Fluorouracil / pharmacology*
  • Humans
  • Light
  • Microscopy, Fluorescence
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Particle Size
  • Rhodamines / metabolism
  • Scattering, Radiation
  • Spectroscopy, Fourier Transform Infrared
  • Static Electricity
  • Temperature
  • X-Ray Diffraction

Substances

  • Antineoplastic Agents
  • Rhodamines
  • Fibrinogen
  • Fluorouracil